Skin Patches

Transdermal drug patches offer the advantages of ease of use, painlessness, disposability, control of drug delivery and avoidance of first-pass metabolism by the liver. New patch designs and formulation technologies are expanding the type and number of prescription therapies and treatments that can be effectively administered to patients and consumers. Advances in synthetic materials and patch design have led to patches that are more esthetically acceptable and that are capable of delivering sustained dosing of active compounds for several days in a smaller package. Growth in demand for prescription drug patches is being driven by several factors – factors with strong demographic and population trend underpinnings.

Publication Date: May 2009

Table of Contents (see Prospectus for full Contents)

Executive Summary

The Transdermal Drug Delivery Marketspace

Skin Patch Economics

Important Patch Drug Therapies

Transdermal Drug Packaging

Demand Drivers

Competitive Landscape

Factors Limiting Growth

Prescription Patch Design & Technology

Patch Architecture

Passive Transdermal Patch Design

Passive Patch Construction

Active Transport Patch Technologies

Evolving Prescription Patch Technologies

Prescription Patch Development Factors

The Design Cycle

Design Partnerships

Patch Product Testing

Trials and Submissions

Pharmacokinetics & Dosage Forms

Patch Manufacturing Dynamics

Patch Manufacturing Company Profiles

Drugs Currently Delivered in Approved Transdermal Patches

Clonidine

Estradiol

Esstradiol/Norethrindone acetate

Fentanyl

Lidocaine

Mecamylamine

Methylphenidate

Nitroglycerin

Norelgestromin

Oxybutynin

Scopolamine

Selegiline

Testosterone

Varenicline

Drugs in Development for Transdermal Patch Delivery Systems

Prescription Patch Design & Acceptance Factors

Dosing and Rate Factors

Materials Compatibility

Clinical Trial Process

Biocompatibility

Market Factors

FDA Regulations

Rx-to-OTC Switching

New Patch Technologies

Skin Patch Revenue Models

FDA-Approved Patch Therapies – Analysis and Market Data

ADHD

Contraception

Cardiovascular/Angina

Depression

Hormone Replacement Therapy

Hypertension

Local Anesthetics

Motion Sickness

Osteoporosis

Pain Management

Emerging Patch Therapeutics – Opportunity and Risk Assessment

Addiction

Alzheimer’s

Antiviral

Asthma

Oncology

Diabetes

Neurology

Reproductive Medicine

Sexual Dysfunction

Vaccines

Profiles of Market Participants

About Our Reports

Our reports are carefully researched and written to provide timely and insightful analysis of key factors and developments shaping the commercial marketplace. The focused nature of our publications is designed to allow readers to identify emerging demand and growth opportunities in selected markets. Numerous charts, tables and graphs complement the text, with evaluations and assessments of current and probable future market developments, technology issues and business factors - information necessary to compete effectively in the global marketplace.